Psoriasis: A review of the role of serotonergic system

African Journal of Biotechnology

Volumn 9, Issue 11, 2010, Pages 1528-1534

  Ronpirin, Chalinee ^a   Tencomnao, Tewin ^b  

^a THAMMASAT UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Gene expression; Genetic polymorphism; Psoriasis; Serotonergic system

Indexed keywords

SEROTONIN; SEROTONIN 2A RECEPTOR; TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN HYDROXYLASE 1; TRYPTOPHAN HYDROXYLASE 2; UNCLASSIFIED DRUG;

GENE ACTIVATION; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE STRUCTURE; GENE SYNTHESIS; GENETIC POLYMORPHISM; HUMAN; NEUROTRANSMISSION; PSORIASIS; REVIEW; SEROTONIN BLOOD LEVEL; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; STRESS;

EID: 77950644360     PISSN: None     EISSN: 16845315     Source Type: Journal    
DOI: 10.5897/ajb10.020     Document Type: Review

References (87)

1. Abel EA, DiCicco LM, Orenberg EK, Fraki JE, Farber EM (1986). Drugs in exacerbation of psoriasis. J. Am. Acad. Dermatol. 15: 1007-1022.
2. Albani D, Vittori A, Batelli S, Polito L, De Mauro S, Galimberti D, Scarpini E, Lovati C, Mariani C, Forloni G (2009). Serotonin transporter gene polymorphic element 5-HTTLPR increases the risk of sporadic Parkinson's disease in Italy. Eur. Neurol. 62: 120-123.
3. Amigo M, Payá M, De Rosa S, Terencio MC (2007). Antipsoriatic effects of avarol-3'-thiosalicylate are mediated by inhibition of TNFalpha generation and NF-kappaB activation in mouse skin. Br. J. Pharmacol. 152: 353-365.
4. Azmitia EC, McEwen BS (1969). Corticosterone regulation of tryptophan hydroxylase in midbrain of the rat. Science, 66: 1274-1276.
5. Azmitia EC (1999). Serotonin neurons, neuroplasticity, and homeostasis of neural tissue. Neuropsychopharmacology, 21 (Suppl. 2): S33-S45.
6. Azmitia EC, Liao B, Chen Y (1993). Increase of tryptophan hydroxylase enzyme protein by dexamethasone in adrenalectomized rat midbrain. J. Neurosci. 13: 5041-5055.
7. Azmitia EC (2001). Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis. Brain Res. Bull. 56: 413-424.
8. Barnes NM, Sharp T (1999). A review of central 5-HT receptors and their function. Neuropharmacology, 38: 1083-1152.
9. Barth JH, Baker H (1986). Generalized pustular psoriasis precipitated by trazodone in the treatment of depression. Br. J. Dermatol. 115: 629-630.
10. Boke O, Gunes S, Kara N, Aker S, Sahin AR, Basar Y, Bagci H (2007). Association of serotonin 2A receptor and lack of association of CYP1A2 gene polymorphism with tardive dyskinesia in a Turkish population. DNA Cell Biol. 26: 527-531.
11. Bos JD, de Rie MA, Teunissen MB, Piskin G (2005). Psoriasis: dysregulation of innate immunity. Br. J. Dermatol. 152: 1098-1107.
12. Bray NJ, Buckland PR, Hall H, Owen MJ, O'Donovan MC (2004). The serotonin-2A receptor gene locus does not contain common polymorphism affecting mRNA levels in adult brain. Mol. Psychiatry, 9: 109-114.
13. Chen K, Yang W, Grimsby J, Shih JC (1992). The human 5-HT2 receptor is encoded by a multiple intron-exon gene. Brain Res. Mol. Brain Res. 14: 20-26.
14. Collier DA, Arranz MJ, Li T, Mupita D, Brown N, Treasure J (1997). Association between 5-HT2A gene promoter polymorphism and anorexia nervosa. Lancet, 350: p. 412.
15. Cote F, Thevenot E, Fligny C, Fromes Y, Darmon M, Ripoche MA, Bayard E, Hanoun N, Saurini F, Lechat P, Dandolo L, Hamon M, Mallet J, Vodjdani G (2003). Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function. Proc. Natl. Acad. Sci. USA. 100: 13525-13530.
16. Cote F, Fligny C, Fromes Y, Mallet J, Vodjdani G (2004). Recent advances in understanding serotonin regulation of cardiovascular function. Trends Mol. Med. 10: 232-238.
17. Darmon MC, Grima B, Cash CD, Maitre M, Mallet J (1986). Isolation of a rat pineal gland cDNA clone homologous to tyrosine and phenylalanine hydroxylases. FEBS Lett. 206: 43-46.
18. Dimon-Gadal S, Gerbaud P, Therond P, Guibourdenche J, Anderson WB, Evain-Brion D, Raynaud F (2000). Increased oxidative damage to fibroblasts in skin with and without lesions in psoriasis. J. Invest. Dermatol. 114: 984-989.
19. Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M, Capron F, Simonneau G, Dartevelle P, Hamon M, Adnot S (2001). Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J. Clin. Invest. 108: 1141-1150.
20. Erdmann J, Shimron-Abarbanell D, Rietschel M, Albus M, Maier W, Korner J, Bondy B, Chen K, Shih JC, Knapp M, Propping P, Nothen MM (1996). Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia. Hum. Genet. 97: 614-619.
21. Fry L, Baker BS (2007). Triggering psoriasis: the role of infections and medications. Clin. Dermatol. 25: 606-615.
22. Geba GP, Ptak W, Anderson GM, Paliwal V, Ratzlaff RE, Levin J, Askenase PW (1996). Delayed-type hypersensitivity in mast celldeficient mice: dependence on platelets for expression of contact sensitivity. J. Immunol. 157: 557-565.
23. Gilissen R, Bakermans-Kranenburg MJ, van Ijzendoorn MH, Linting M (2008). Electrodermal reactivity during the Trier Social Stress Test for children: interaction between the serotonin transporter polymorphism and children's attachment representation. Dev. Psychobiol. 50: 615-625.
24. Glennon RA (2003). Higher-end serotonin receptors: 5-HT5, 5-HT6, and 5-HT7. J. Med. Chem. 46: 2795-2812.
25. Griffiths CEM, Richards HL (2001). Psychological influences in psoriasis. Clin. Exp. Dermatol. 26: 338-342.
26. Halder I, Muldoon MF, Ferrell RE, Manuck SB (2007). Serotonin Receptor 2A (HTR2A) Gene Polymorphisms Are Associated with Blood Pressure, Central Adiposity, and the Metabolic Syndrome. Metab. Syndr. Relat. Disord. 5: 323-330.
27. Henseler T (1998). Genetics of psoriasis. Arch. Dermatol. Res. 290: 463-476.
28. Huang J, Li G, Xiang J, Yin D, Chi R (2004). Immunohistochemical study of serotonin in lesions of psoriasis. Int. J. Dermatol. 43: 408-411.
29. Jacobs BL, Azmitia EC (1992). Structure and function of the brain serotonin system. Physiol. Rev. 72: 165-229.
30. Kasperska-Zajac A, Brzoza Z, Rogala B (2008). Platelet function in cutaneous diseases. Platelets, 19: 317-321.
31. Kema IP, de Vries EGE, Muskiet FAJ (2000). Clinical chemistry of serotonin and metabolites. J. Chromatogr. B Biomed. Sci. Appl. 747: 33-48.
32. Kharaeva Z, Gostova E, De Luca C, Raskovic D, Korkina L (2009). Clinical and biochemical effects of coenzyme Q(10), vitamin E, and selenium supplementation to psoriasis patients. Nutrition, 25: 295-302.
33. Kling A, Seddighzadeh M, Arlestig L, Alfredsson L, Rantapää-Dahlqvist S, Padyukov L (2008). Genetic variations in the serotonin 5-HT2A receptor gene (HTR2A) are associated with rheumatoid arthritis. Ann. Rheum. Dis. 67: 1111-1115.
34. Koczan D, Guthke R, Thiesen HJ, Ibrahim SM, Kundt G, Krentz H, Gross G, Kunz M (2005). Gene expression profiling of peripheral blood mononuclear leukocytes from psoriasis patients identifies new immune regulatory molecules. Eur. J. Dermatol. 15: 251-257.
35. Kunz M, Ibrahim SM, Koczan D, Scheid S, Thiesen HJ, Gross G (2004). DNA microarray technology and its applications in dermatology. Exp. Dermatol. 13: 593-606.
36. Langewouters AM, van Erp PE, de Jong EM, van de Kerkhof PC (2008). Lymphocyte subsets in peripheral blood of patients with moderate-to-severe versus mild plaque psoriasis. Arch. Dermatol. Res. 300: 107-113.
37. Lechin F, van der Dijs B, Lechin AE (2004). Treatment of bronchial asthma with tianeptine. Methods Find. Exp. Clin. Pharmacol. 26: 697-701.
38. Lechin F, van der Dijs B, Hernández G, Orozco B, Rodríguez S, Baez S (2006). Acute effects of tianeptine on circulating neurotransmitters and cardiovascular parameters. Prog. Neuropsychopharmacol. Biol. Psychiatry, 30: 214-222.
39. Lee HJ, Sung SM, Lim SW, Paik JW, Leen Kim (2006). Seasonality associated with the serotonin 2A receptor -1438 A/G polymorphism. J. Affect. Disord. 95: 145-148.
40. Leon-Ponte M, Ahern GP, O'Connell PJ (2007). Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor. Blood, 109: 3139-3146.
41. Lesch KP, Mossner R (1998). Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders? Biol. Psychiatry, 44: 179-192.
42. Li D, He L (2007). Meta-analysis supports association between serotonin transporter (5-HTT) and suicidal behavior. Mol. Psychiatry, 12: 47-54.
43. Liu Z, Tan S, Yu C, Fan J, Bai Z, Junjie Li (2007). A preliminary screening study on the associated proteins in human psoriasis vulgaris by serum proteomics technologies. J.N.M.U. 21: 272-276.
44. Locala JA (2009). Current concepts in psychodermatology. Curr. Psychiatry Rep. 11: 211-218.
45. Lonsdorf TB, Rück C, Bergström J, Andersson G, Ohman A, Schalling M, Lindefors N (2009). The symptomatic profile of panic disorder is shaped by the 5-HTTLPR polymorphism. Prog. Neuropsychopharmacol. Biol. Psychiatry, 33: 1479-1483.
46. Lowes MA, Bowcock AM, Krueger JG (2007). Pathogenesis and therapy of psoriasis. Nature, 445: 866-873.
47. Millington GW (2008). Epigenetics and dermatological disease. Pharmacogenomics, 9: 1835-1850.
48. Misery L (1997). Skin, immunity and the nervous system. Br. J. Dermatol. 137: 843-850.
49. Mossner R, Lesch KP (1998). Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav. Immun. 12: 249-271.
50. Mossner R, Stiens G, Konig IR, Schmidt D, Platzer A, Krüger U, Reich K (2009). Analysis of a functional serotonin transporter promoter polymorphism in psoriasis vulgaris. Arch. Dermatol. Res. 301: 443-447.
51. Mueller A, Brocke B, Fries E, Lesch KP, Kirschbaum C (2010). The role of the serotonin transporter polymorphism for the endocrine stress response in newborns. Psychoneuroendocrinology, 35: 289-296.
52. Myers RL, Airey DC, Manier DH, Shelton RC, Sanders-Bush E (2007). Polymorphisms in the regulatory region of the human serotonin 5- HT2A receptor gene (HTR2A) influence gene expression. Biol. Psychiatry, 61: 167-173.
53. Nordlind K, Thorslund K, Lonne-Rahm S, Mohabbati S, Berki T, Morales M, Azmitia EC (2006). Expression of serotonergic receptors in psoriatic skin. Arch. Dermatol. Res. 298: 99-106.
54. O'Connell PJ, Wang X, Leon-Ponte M, Griffiths C, Pingle SC, Ahern GP (2006). A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells. Blood, 107: 1010-1017.
55. Ohara K, Nagai M, Tani K, Tsukamoto T, Ohara K (1999). Schizophrenia and the serotonin-2A receptor promoter polymorphism. Psychiatry Res. 85: 221-224.
56. Okayama Y (2005). Oxidative stress in allergic and inflammatory skin diseases. Curr. Drug Targets Inflamm. Allergy, 4: 517-519.
57. Ono H, Shirakawa O, Nishiguchi N, Nishimura A, Nushida H, Ueno Y, Maeda K (2001). Serotonin 2A receptor gene polymorphism is not associated with completed suicide. J. Psychiatr. Res. 35: 173-176.
58. Osborne SF, Stafford L, Orr KG (2002). Paroxetine-associated psoriasis. Am. J. Psychiatry, 159: 2113.
59. O'Sullivan RL, Lipper G, Lerner EA (1998). The neuro-immunocutaneous-endocrine network: relationship of mind and skin. Arch. Dermatol. 134: 1431-1435.
60. Parsons MJ, D'Souza UM, Arranz MJ, Kerwin RW, Makoff AJ (2004). The -1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity. Biol. Psychiatry, 56: 406-410.
61. Peters BP, Weissman FG, Gill MA (2000). Pathophysiology and treatment of psoriasis. Am. J. Health. Syst. Pharm. 57: 645-659.
62. Prinz JC (2003). The role of T cells in psoriasis. J. Eur. Acad. Dermatol. Venereol. 17: 257-270.
63. Prinz JC (2009). The role of streptococci in psoriasis. Hautarzt 60: 109-115.
64. Rapport MM, Green AA, Page IH (1948). Crystalline Serotonin. Science, 108: 329-330.
65. Reich A, Szepietowski JC (2007). Mediators of pruritus in psoriasis. Mediators Inflamm. 2007: 64727.
66. Relhan V, Gupta SK, Dayal S, Pandey R, Lal H (2002). Blood thiols and malondialdehyde levels in psoriasis. J. Dermatol. 29: 399-403.
67. Rocha-Pereira P, Santos-Silva A, Rebelo I, Figneiredo A, Quintanilha A, Teixeira F (2004). Erythrocyte damage in mild and severe psoriasis. Br. J. Dermatol. 150: 232-244.
68. Ruchusatsawat K, Wongpiyabovorn J, Shuangshoti S, Hirankarn N, Mutirangura A (2006). SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis. J. Mol. Med. 84: 175-182.
69. Saltzman AG, Morse B, Whitman MM, Ivanshchenko Y, Jaye M, Felder S (1991). Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes. Biochem. Biophys. Res. Commun. 181: 1469-1478.
70. Schon MP, Boehncke WH (2005). Psoriasis. N. Engl. J. Med. 352: 1899-1912.
71. Sezer E, Ozugurlu F, Ozyurt H, Sahin S, Etikan I (2007). Lipid peroxidation and antioxidant status in lichen planus. Clin. Exp. Dermatol. 32: 430-434.
72. Shilov VN, Sergienko VI (2000). Oxidative stress in keratinocytes as an etiopathogenetic factor of psoriasis. Bull. Exp. Biol. Med. 129: 364-369.
73. Smith AK, Dimulescu I, Falkenberg VR, Narasimhan S, Heim C, Vernon SD, Rajeevan MS (2008). Genetic evaluation of the serotonergic system in chronic fatigue syndrome. Psychoneuroendocrinology, 33: 188-197.
74. Stefulj J, Jernej B, Cicin-Sain L, Rinner I, Schauenstein K (2000). mRNA expression of serotonin receptors in cells of the immune tissues of the rat. Brain Behav. Immun. 14: 219-224.
75. Tan Pei Lin L, Kwek SK (in press). Onset of psoriasis during therapy with fluoxetine. Gen. Hosp. Psychiatry. DOI:10.1016/j.genhosppsych. 2009.08.008
76. Tencomnao T, Ketboonlue K, Wongpiyabavorn J, Ronpirin C, Achariyakul M, Laiwattanapaisal W, Chuchawankul S (2007). Analysis of autoantibodies to serotonin and serotonin levels in psoriasis. Chin. Med. J. (Engl.) 120 (Suppl. 2): P07-02.
77. Thorslund K, El-Nour H, Nordlind K (2009). The serotonin transporter protein is expressed in psoriasis, where it may play a role in regulating apoptosis. Arch. Dermatol. Res. 301: 449-457.
78. Toker A, Kadi M, Yildirim AK, Aksoy H, Akçay F (2009). Serum lipid profile paraoxonase and arylesterase activities in psoriasis. Cell Biochem. Funct. 27: 176-180.
79. Trcka J, Kunz M (2006). Functional genome and proteome analyses of cutaneous autoimmune diseases. Curr. Pharm. Des. 12: 3787-3798.
80. Trouba KJ, Hamadeh HK, Amin RP, Germolec DR (2002). Oxidative stress and its role in skin disease. Antioxid. Redox Signal. 4: 665-673.
81. Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ (1993). The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J. Invest. Dermatol. 101: 701-705.
82. van Lingen RG, Korver JE, van de Kerkhof PC, Berends MA, van Rens DW, Langewouters AM, Boezeman JB, Seyger MM, de Jong EM (2008). Relevance of compartmentalization of T-cell subsets for clinical improvement in psoriasis: effect of immune-targeted antipsoriatic therapies. Br. J. Dermatol. 159: 91-96.
83. Verge D, Calas A (2000). Serotonergic neurons and serotonin receptors: gains from cytochemical approaches. J. Chem. Neuroanat. 18: 41-56.
84. Walther DJ, Peter JU, Bashammakh S, Hortnagl H, Voits M, Fink H, Bader M (2003). Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science, 299: p. 76.
85. Wolters M (2005). Diet and psoriasis: experimental data and clinical evidence. Br. J. Dermatol. 153: 706-714.
86. Warren Jr. JT, Peacock ML, Rodriguez LC, Fink JK (1993). An MspI polymorphism in the hyman serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis. Hum. Mol. Genet. 2: 338.
87. Zhou Q, Mrowietz U, Rostami-Yazdi M (2009). Oxidative stress in the pathogenesis of psoriasis. Free Radic. Biol. Med. 47: 891-905.